Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on discovering breakthrough treatment for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
1.45
+0.01 (+0.69%)
Range 1.43 - 1.51
Open N/A
Prev Close 1.44
52 Week 1.04 - 2.45
Volume 2120144
Market Cap 746.5M
*Delayed 10/31/2014 4:00 EDT

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000